Itron (NASDAQ:ITRI) SVP Donald Reeves III Sells 277 Shares

22 May 2026, 09:20 by Doug Wharley · The Cerbat Gem

Itron, Inc. (NASDAQ:ITRI – Get Free Report) SVP Donald Reeves III sold 277 shares of the firm’s stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $79.60, for a total transaction of $22,049.20. Following the completion of the sale, the senior vice president owned 29,674 shares in the company, valued at $2,362,050.40. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Stock Up 0.6%

NASDAQ:ITRI opened at $81.85 on Friday. Itron, Inc. has a fifty-two week low of $77.77 and a fifty-two week high of $142.00. The stock has a market capitalization of $3.63 billion, a P/E ratio of 13.05, a P/E/G ratio of 0.71 and a beta of 1.35. The company has a debt-to-equity ratio of 0.97, a quick ratio of 2.24 and a current ratio of 2.66. The company’s 50-day simple moving average is $88.63 and its 200-day simple moving average is $94.60.

Itron (NASDAQ:ITRI – Get Free Report) last released its quarterly earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.23. The business had revenue of $586.98 million for the quarter, compared to analysts’ expectations of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. The company’s revenue was down 3.3% compared to the same quarter last year. During the same period last year, the business earned $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, equities analysts anticipate that Itron, Inc. will post 6.01 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently commented on ITRI shares. TD Cowen lowered their target price on shares of Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Needham & Company LLC started coverage on shares of Itron in a research note on Friday, March 6th. They issued a “buy” rating and a $124.00 target price for the company. JPMorgan Chase & Co. lowered their target price on shares of Itron from $133.00 to $113.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Guggenheim set a $155.00 target price on shares of Itron in a research note on Friday, February 13th. Finally, Stephens reiterated an “overweight” rating and issued a $130.00 target price on shares of Itron in a research note on Wednesday. Eight research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Itron currently has an average rating of “Moderate Buy” and a consensus target price of $131.22.

Check Out Our Latest Analysis on ITRI

Key Stories Impacting Itron

Here are the key news stories impacting Itron this week:

Positive Sentiment: Stephens reaffirmed its Overweight rating on Itron and kept a $130 price target, implying substantial upside from the current share price. Stephens reaffirms Overweight on Itron
Neutral Sentiment: Several Itron executives sold small blocks of shares, but the filings say the transactions were mainly to cover tax withholding from equity award vesting, which makes the insider activity less concerning than open-market selling. SEC filing for insider sale
Negative Sentiment: Zacks Research cut multiple earnings estimates for Itron, including a sharp reduction for Q4 2027 and a lower FY2027 forecast, signaling softer profit expectations ahead. Zacks Research estimate cuts for Itron

Hedge Funds Weigh In On Itron

Several large investors have recently made changes to their positions in the company. California State Teachers Retirement System lifted its stake in shares of Itron by 28.3% in the 1st quarter. California State Teachers Retirement System now owns 55,042 shares of the scientific and technical instruments company’s stock valued at $4,933,000 after purchasing an additional 12,154 shares during the period. Entropy Technologies LP lifted its stake in shares of Itron by 6.3% in the 1st quarter. Entropy Technologies LP now owns 8,278 shares of the scientific and technical instruments company’s stock valued at $742,000 after purchasing an additional 490 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Itron by 10.1% in the 1st quarter. Renaissance Technologies LLC now owns 461,761 shares of the scientific and technical instruments company’s stock valued at $41,388,000 after purchasing an additional 42,300 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in shares of Itron by 12.2% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 673,420 shares of the scientific and technical instruments company’s stock valued at $60,359,000 after purchasing an additional 73,020 shares during the period. Finally, Caxton Associates LLP purchased a new stake in Itron in the 1st quarter worth $2,212,000. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Itron Company Profile

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.